Contact Us
NovoEight Global Market Report 2025
Global NovoEight Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

NovoEight Global Market Report 2025

By Indication (Hemophilia A, Surgical Procedures), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales), By End User (Adult, Pediatric, Geriatric, Hospitals Or Clinics, Homecare Settings)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under NovoEight Market?

NovoEight refers to turoctocog alfa, which is a recombinant coagulation factor VIII. It is utilized to treat and prevent bleeding in individuals with hemophilia A, a genetic disorder characterized by a deficiency of factor VIII, an essential blood-clotting protein.

The main types of indications in novoeight are hemophilia A and surgical procedures. Hemophilia A is a genetic disorder where blood doesn't clot properly due to a lack of clotting factor VIII. It is distributed through hospital pharmacies, retail pharmacies, online pharmacies, and direct sales, catering to various end users such as pediatric, geriatric, hospitals or clinics, and homecare settings.

NovoEight Market Size and growth rate 2025 to 2029: Graph

What Is The NovoEight Market Size 2025 And Growth Rate?

The novoeight market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to implementing educational programs, development of prophylactic treatment protocols, better safety profile, increasing support from health systems and growing emphasis on improving the quality of life.

What Is The NovoEight Market Growth Forecast?

The novoEight market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising patient awareness, increasing use of prophylactic treatment, home treatment and self-administration growth, expansion of hemophilia treatment centers, and growing government investments. Major trends in the forecast period include patient-centered innovation, innovations in biotechnology, integration of telemedicine, advanced treatment centers, and integration with electronic health records (EHRs)

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The NovoEight Market Segmented?

The novoeight market covered in this report is segmented –

1) By Indication: Hemophilia A; Surgical Procedures

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales

3) By End User: Adult; Pediatric; Geriatric; Hospitals Or Clinics; Homecare Settings

What Is Driving The NovoEight Market? Rising Prevalence Of Hemophilia Is Driving The Growth Of The Market.

The rising prevalence of hemophilia is expected to propel the growth of the novoeight market going forward. Hemophilia refers to a genetic disorder in which the blood doesn't clot properly, leading to excessive bleeding, even from minor injuries. The rising prevalence of hemophilia is due to improved diagnostic techniques, greater awareness, and better reporting systems, which have led to more individuals being identified and diagnosed with the condition. NovoEight helps individuals with hemophilia effectively control and prevent bleeding episodes, enabling improved clotting function, reducing the risk of spontaneous bleeding, and enhancing overall mobility and quality of life for patients. For instance, in October 2022, according to the World Federation of Hemophilia, a Canada-based non-profit organization, in 2022, a total of 427,685 individuals worldwide were diagnosed with bleeding disorders, including 257,146 cases of hemophilia (208,957 of hemophilia A, 42,203 of hemophilia B, and 5,986 with an unspecified type), 100,505 cases of von Willebrand disease, and 70,034 cases of other bleeding disorders. Therefore, the rising prevalence of hemophilia is driving the growth of the novoeight market.

What Is Driving The NovoEight Market? Rising Demand For Personalized Medicine Is Driving The Growth Of The Market.

The rising demand for personalized medicine is expected to propel the growth of the novoeight market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to individual patients based on their genetic, environmental, and lifestyle factors. The rising demand for personalized medicine is due to advances in genetic research, increased awareness of individualized treatments, and the desire for more effective, targeted therapies that minimize side effects and improve patient outcomes. Novoeight, a recombinant factor VIII therapy, plays a pivotal role in personalized medicine by offering tailored treatment options for patients with hemophilia A, allowing healthcare providers to customize dosing regimens based on individual patient needs, genetic profiles, and response to therapy, ultimately improving treatment outcomes and quality of life. For instance, in February 2024, the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approvals in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the novoeight market.

What Is Driving The NovoEight Market? Increasing Healthcare Expenditure Is Driving The Growth Of The Market

The increasing healthcare expenditure is expected to propel the growth of the novoeight market going forward. Healthcare expenditure is the total resources spent on healthcare services and goods within a specific region, country, or globally. Healthcare expenditure is increasing due to aging populations, advancements in medical technologies, rising prevalence of chronic diseases, higher patient expectations, and inflation in healthcare service costs. Novoeight is a recombinant factor VIII therapy used for managing hemophilia A and helps reduce healthcare expenditure by minimizing the frequency of bleeding episodes, decreasing the need for emergency interventions, enabling better long-term management of the condition, lowering overall treatment costs, and improving patient quality of life. For instance, in December 2023, according to a report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, in 2022, U.S. healthcare spending increased by 4.1% to reach $4.5 trillion, a notable rise compared to the 3.2% growth recorded in 2021. Therefore, the increasing healthcare expenditure is driving the growth of the novoeight market.

Who Are The Major Players In The Global NovoEight Market?

Major companies operating in the novoeight market are Novo Nordisk A/S

Need data on a specific region in this market?

Regional Analysis For The Global NovoEight Market

North America was the largest region in the novoeight market in 2024. The regions covered in the novoeight market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the novoeight market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the NovoEight Market?

The novoeight market consists of sales of novoeight (recombinant factor VIII), novoseven (recombinant factor VII), novoeight [RFVIII]—lyophilized powder, and novoeight [RFVIII] prefilled syringe. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the NovoEight Industry?

The novoeight market research report is one of a series of new reports from The Business Research Company that provides novoeight market statistics, including novoeight industry global market size, regional shares, competitors with a novoeight market share, detailed novoeight market segments, market trends and opportunities, and any further data you may need to thrive in the novoeight industry. This novoeight market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

NovoEight Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The novoeight market covered in this report is segmented –
1) By Indication: Hemophilia A; Surgical Procedures
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales
3) By End User: Adult; Pediatric; Geriatric; Hospitals Or Clinics; Homecare Settings
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Novo Nordisk A/S
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. NovoEight Market Characteristics

3. NovoEight Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. NovoEight Market Trends And Strategies

5. NovoEight Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global NovoEight Growth Analysis And Strategic Analysis Framework

6.1. Global NovoEight PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global NovoEight Market Growth Rate Analysis

6.4. Global NovoEight Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global NovoEight Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global NovoEight Total Addressable Market (TAM)

7. Global NovoEight Pricing Analysis & Forecasts

8. NovoEight Market Segmentation

8.1. Global NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hemophilia A

Surgical Procedures

8.2. Global NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Direct Sales

8.3. Global NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult

Pediatric

Geriatric

Hospitals Or Clinics

Homecare Settings

9. Global NovoEight Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. NovoEight Market Regional And Country Analysis

10.1. Global NovoEight Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global NovoEight Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific NovoEight Market

11.1. Asia-Pacific NovoEight Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China NovoEight Market

12.1. China NovoEight Market Overview

12.2. China NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India NovoEight Market

13.1. India NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan NovoEight Market

14.1. Japan NovoEight Market Overview

14.2. Japan NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia NovoEight Market

15.1. Australia NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea NovoEight Market

16.1. South Korea NovoEight Market Overview

16.2. South Korea NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe NovoEight Market

17.1. Western Europe NovoEight Market Overview

17.2. Western Europe NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK NovoEight Market

18.1. UK NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany NovoEight Market

19.1. Germany NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France NovoEight Market

20.1. France NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe NovoEight Market

21.1. Eastern Europe NovoEight Market Overview

21.2. Eastern Europe NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America NovoEight Market

22.1. North America NovoEight Market Overview

22.2. North America NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA NovoEight Market

23.1. USA NovoEight Market Overview

23.2. USA NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada NovoEight Market

24.1. Canada NovoEight Market Overview

24.2. Canada NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America NovoEight Market

25.1. South America NovoEight Market Overview

25.2. South America NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East NovoEight Market

26.1. Middle East NovoEight Market Overview

26.2. Middle East NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa NovoEight Market

27.1. Africa NovoEight Market Overview

27.2. Africa NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. NovoEight Market Competitive Landscape And Company Profiles

28.1. NovoEight Market Competitive Landscape

28.2. NovoEight Market Company Profiles

28.2.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

29. Global NovoEight Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global NovoEight Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The NovoEight Market

32. Recent Developments In The NovoEight Market

33. NovoEight Market High Potential Countries, Segments and Strategies

33.1 NovoEight Market In 2029 - Countries Offering Most New Opportunities

33.2 NovoEight Market In 2029 - Segments Offering Most New Opportunities

33.3 NovoEight Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global NovoEight Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global NovoEight Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Novo Nordisk A/S Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global NovoEight Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global NovoEight Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Novo Nordisk A/S Financial Performance

Frequently Asked Questions

NovoEight refers to turoctocog alfa, which is a recombinant coagulation factor VIII. It is utilized to treat and prevent bleeding in individuals with hemophilia A, a genetic disorder characterized by a deficiency of factor VIII, an essential blood-clotting protein. For further insights on the NovoEight market, request a sample here

The NovoEight market major growth driver - Rising Prevalence Of Hemophilia Is Driving The Growth Of The Market.. For further insights on the NovoEight market, request a sample here

The NovoEight market size has grown strongly in recent years. The novoeight market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to implementing educational programs, development of prophylactic treatment protocols, better safety profile, increasing support from health systems and growing emphasis on improving the quality of life. The novoEight market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising patient awareness, increasing use of prophylactic treatment, home treatment and self-administration growth, expansion of hemophilia treatment centers, and growing government investments. Major trends in the forecast period include patient-centered innovation, innovations in biotechnology, integration of telemedicine, advanced treatment centers, and integration with electronic health records (EHRs) For further insights on the NovoEight market, request a sample here

The novoeight market covered in this report is segmented –
1) By Indication: Hemophilia A; Surgical Procedures
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales
3) By End User: Adult; Pediatric; Geriatric; Hospitals Or Clinics; Homecare Settings For further insights on the NovoEight market,
request a sample here

North America was the largest region in the novoeight market in 2024. The regions covered in the novoeight market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the NovoEight market, request a sample here.

Major companies operating in the novoeight market are Novo Nordisk A/S . For further insights on the NovoEight market, request a sample here.

Major trends in the NovoEight market include . For further insights on the NovoEight market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon